A detailed history of Riverview Capital Advisers, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Riverview Capital Advisers, LLC holds 12,957 shares of AZN stock, worth $850,367. This represents 0.32% of its overall portfolio holdings.

Number of Shares
12,957
Previous 12,957 -0.0%
Holding current value
$850,367
Previous $1.01 Million 0.1%
% of portfolio
0.32%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$61.89 - $69.28 $2,289 - $2,563
37 Added 0.29%
12,957 $872,000
Q4 2021

Feb 07, 2023

BUY
$54.02 - $63.83 $697,938 - $824,683
12,920 New
12,920 $753 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Riverview Capital Advisers, LLC Portfolio

Follow Riverview Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Capital Advisers, LLC with notifications on news.